{"nct_id":"NCT04564547","title":"Dose Ranging, Switch Study of Islatravir (ISL) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2021-03-09","start_date_type":"ACTUAL","primary_completion_date":"2025-01-30","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}